ANTIBODY CHELATES AND CONJUGATES
ANTIBODY CHELATES AND CONJUGATES
批准号:
6236864
负责人:
John Ernest Shively
金额:
$24.29万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 1998-04-30
关键词:
Mammalia antitumor antibody carcinoembryonal antigen chelating agents chemical synthesis crosslink hybrid antibody immunochemistry immunoconjugates immunoglobulin structure ion exchange chromatography mass spectrometry metal complex monoclonal antibody nuclear magnetic resonance spectroscopy pharmacokinetics protein engineering radionuclides
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Novel bifunctional chelates and metal ion complexes will be synthesized
and conjugated to anti-CEA (carcinoembryonic antigen) antibodies for their
improved targeting in CEA positive tumors. The new bifunctional chelates
are based on the macrocycle DOTA and incorporate new pendant functional
groups to enhance metal ion binding on the antibody conjugate. the
functional groups include carboxyl, sulfhydryl, hydrazides, and
acetohydroxamates. these groups are expected to form tight "type I"
complexes with In-111, Y-90, nd Cu-64. The radiometals were chosen for
their utility in radioimmuno-imaging and therapy. Conditions of pH,
temperature, and choice of transchelator will be optimized for the
conjugate for each metal ion, and stability constants for the "type I"
complexes will be measured in serum. in addition the stability constants
for the "type II" complexes will be measured in 10 mM DTPA. Simplified
synthetic routes have been devised for each bifunctional chelator. The
products will be purified by ion exchange chromatography and analyzed by
mass spectrometry and NMR. The bifunctional chelators will be attached
with or without linkers to whole and antibody fragments, engineered in
Project 2. Non-specific attachment will be to lysine residues and site
specific attachment will be to cysteine residues in the hinge region or
those engineered into the CH3 domain, and to aldehydes produced by
periodate oxidation of engineered glycosyl residues. Chemically labile
liners that improve tumor to blood ratios without lowering tumor uptake of
the sulfur atom in the linker. Animal studies will be performed to
determine the ultimate metabolic fate of the metal complex ina the liver,
kidney, and tumor. The overall approach is expected to lead to clinical
products with improved labeling and biodistribution properties. The
assembled team has unique expertise in chemistry, antibody conjugation,
and the use of animal models for evaluating radiolabeled antibodies in
pre-clinical and clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted radiation and immunocytokine therapy for CEA positive malignancies
-
批准号:10720201
-
项目类别:
-
资助金额:$67.63万
-
财政年份:2023
-
负责人:John Ernest Shively
-
依托单位:
IMMUNOLOGICAL AND GENETIC ANALYSIS OF AUTOINFLAMMATORY GENES IN FIBROMYALGIA
-
批准号:7982064
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2008
-
负责人:John Ernest Shively
-
依托单位:
IMMUNOLOGICAL AND GENETIC ANALYSIS OF AUTOINFLAMMATORY GENES IN FIBROMYALGIA
-
批准号:7716649
-
项目类别:
-
资助金额:$6.01万
-
财政年份:2008
-
负责人:John Ernest Shively
-
依托单位:
OPTICAL BIOSENSOR FOR THE EARLY DETECTION OF BREAST CANCER
-
批准号:7603863
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2006
-
负责人:John Ernest Shively
-
依托单位:
IMMUNOLOGICAL AND GENETIC ANALYSIS OF AUTOINFLAMMATORY GENES IN FIBROMYALGIA
-
批准号:7603880
-
项目类别:
-
资助金额:$5.72万
-
财政年份:2006
-
负责人:John Ernest Shively
-
依托单位:
IMMUNOLOGICAL AND GENETIC ANALYSIS OF AUTOINFLAMMATORY GENES IN FIBROMYALGIA
-
批准号:7368180
-
项目类别:
-
资助金额:$3.05万
-
财政年份:2005
-
负责人:John Ernest Shively
-
依托单位:
OPTICAL BIOSENSOR FOR THE EARLY DETECTION OF BREAST CANCER
-
批准号:7368159
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:John Ernest Shively
-
依托单位:
ROLE OF BGP IN BREAST EPITHELIAL CELL POLARIZATION
-
批准号:6192179
-
项目类别:
-
资助金额:$41.77万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
ROLE OF BGP IN BREAST EPITHELIAL CELL POLARIZATION
-
批准号:6754354
-
项目类别:
-
资助金额:$42.29万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
ANTIBODY CHELATES AND CONJUGATES
-
批准号:6300283
-
项目类别:
-
资助金额:$15.65万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
ROLE OF BGP IN BREAST EPITHELIAL CELL POLARIZATION
-
批准号:6514274
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
Role of CEACAM1 in Epithelial Cell Polarization
-
批准号:7822777
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
Role of CEACAM1 in Epithelial Cell Polarization
-
批准号:7423906
-
项目类别:
-
资助金额:$40.43万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
ROLE OF BGP IN BREAST EPITHELIAL CELL POLARIZATION
-
批准号:6377667
-
项目类别:
-
资助金额:$38.79万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
ROLE OF BGP IN BREAST EPITHELIAL CELL POLARIZATION
-
批准号:6633567
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
Role of CEACAM1 in Epithelial Cell Polarization
-
批准号:7623472
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2000
-
负责人:John Ernest Shively
-
依托单位:
Role of CEACAM1 in Epithelial Cell Polarization
-
批准号:7102142
-
项目类别:
-
资助金额:$40.02万
-
财政年份:1999
-
负责人:John Ernest Shively
-
依托单位:
ANTIBODY CHELATES AND CONJUGATES
-
批准号:6102343
-
项目类别:
-
资助金额:$15.65万
-
财政年份:1999
-
负责人:John Ernest Shively
-
依托单位:
Role of CEACAM1 in Epithelial Cell Polarization
-
批准号:7231349
-
项目类别:
-
资助金额:$40.03万
-
财政年份:1999
-
负责人:John Ernest Shively
-
依托单位:
ANTIBODY CHELATES AND CONJUGATES
-
批准号:6269267
-
项目类别:
-
资助金额:$23.57万
-
财政年份:1998
-
负责人:John Ernest Shively
-
依托单位:
海外基金